NASDAQ:CFRX
ContraFect Corporation
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.contrafect.comipo date
Sep 12, 2014
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company a...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus